Trust Signals
Written by the FormBlends Medical Team. Evidence claims are graded by study type. This page cites only real, traceable sources. Speculative claims are explicitly labeled. Last reviewed 2026-05-29.
Key Takeaways
- Sermorelin is a 29-amino-acid GHRH analogue with a plasma half-life of roughly 10 to 20 minutes, making injection timing and pulse physiology central to proper use.
- Subcutaneous injection is the only administration route with demonstrated pharmacodynamic activity in humans; oral forms have no published efficacy data.
- Clinical trial doses were roughly in the 0.2 to 0.3 mg per day range; compounding prescriptions commonly range from 100 to 300 mcg nightly.
- Nighttime dosing, in a fasted or low-carbohydrate state, is mechanistically justified by the dominant GH pulse that occurs during early slow-wave sleep.
- Reconstituted sermorelin stored at 2 to 8 degrees Celsius should be discarded if cloudy or if more than roughly 30 days have passed since reconstitution.
What Is Sermorelin and How Do You Take It? (Direct Answer)
How to take sermorelin peptide: subcutaneous injection is required. You reconstitute the lyophilized powder with bacteriostatic water, calculate your dose in micrograms per unit volume, and inject into abdominal subcutaneous fat at night. No oral or topical form has demonstrated bioavailability in peer-reviewed human research. A valid prescription is legally required in the United States.
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.
Try the BMI Calculator →Table of Contents
- What is sermorelin and how does it work mechanistically?
- What does the evidence actually show?
- How do you reconstitute sermorelin correctly?
- How do you inject sermorelin?
- What dose should you use?
- When is the best time to take sermorelin?
- What do most guides get wrong about sermorelin?
- How long does reconstituted sermorelin stay potent?
- How does sermorelin compare to alternatives?
- How do you read a sermorelin label and COA?
- FAQ
What Is Sermorelin and How Does It Work Mechanistically?
Sermorelin acetate is a synthetic analogue of endogenous growth hormone-releasing hormone (GHRH), consisting of the first 29 amino acids of the 44-amino-acid native peptide. This truncated sequence retains full binding activity at the GHRH receptor (GHRHR), a Gs-protein-coupled receptor expressed on somatotroph cells of the anterior pituitary. Receptor binding activates adenylyl cyclase, raises intracellular cyclic AMP, and triggers both growth hormone (GH) synthesis and pulsatile GH secretion into circulation.
Because sermorelin acts upstream at the pituitary rather than replacing GH directly, it preserves the negative-feedback loop. Rising IGF-1 and somatostatin still suppress release, which is the physiologic brake that direct GH injection bypasses. This upstream mechanism is the mechanistic argument for a safer IGF-1 trajectory, though clinical evidence directly comparing sermorelin to GH on safety outcomes in adults is limited.
Plasma half-life is short, roughly 10 to 20 minutes based on pharmacokinetic data from the original Geref product labeling, meaning each injection produces a transient GH pulse rather than sustained elevation. This short half-life makes injection timing consequential in a way it is not for long-acting analogues.
What Does the Evidence Actually Show?
| Claim | Best Evidence Type | Effect Direction | Confidence |
|---|---|---|---|
| Sermorelin raises GH and IGF-1 in adults with GH deficiency | Human RCTs and open-label trials (Geref era, FDA registration data) | Positive, robust in GHD populations | High (for GHD indication) |
| Sermorelin improves body composition in adults | Small controlled trials and open-label studies in older adults (e.g., Vittone et al. 1997, Corpas et al. 1992) | Modest positive; effect size smaller than exogenous GH | Moderate |
| Subcutaneous injection is the effective route | PK/PD data from clinical trials; mechanism-level evidence | Clearly positive | High |
| Oral sermorelin is bioavailable | No published human data | No evidence of effect | Very Low |
| Nighttime dosing amplifies GH pulse | Mechanistic/circadian physiology; indirect clinical data | Positive, mechanistically sound | Moderate |
| Sermorelin improves sleep quality | Small exploratory studies; subjective reports | Directionally positive; underpowered | Low |
| Sermorelin is safer than exogenous GH long-term | Mechanistic argument; no head-to-head RCT in adults | Plausible; not proven | Very Low |
How Do You Reconstitute Sermorelin Correctly?
Sermorelin arrives as a white lyophilized (freeze-dried) powder in a sealed vial. You must reconstitute it before use. Here is the correct procedure:
- Wipe the vial stopper and the bacteriostatic water vial with an alcohol swab and let them dry for 10 to 15 seconds.
- Draw the desired volume of bacteriostatic water into an insulin syringe. A common starting ratio is 2 mL of bacteriostatic water added to a 6 mg vial, producing a concentration of 3 mg per mL (3,000 mcg per mL).
- Insert the needle at a 45-degree angle and inject the water slowly down the inner wall of the vial. Do not aim the stream directly at the powder cake. Do not shake.
- Gently swirl the vial between your palms until the powder is fully dissolved. The solution should be clear and colorless. Any cloudiness, visible particles, or color should prompt you to discard the vial.
- Calculate your dose volume. If your vial concentration is 3,000 mcg per mL and your prescribed dose is 300 mcg, you draw 0.1 mL (10 units on a 100-unit insulin syringe).
How Do You Inject Sermorelin?
Sermorelin is given subcutaneously (into fat tissue just below the skin), not intramuscularly. The most common sites are the periumbilical abdomen (at least 2 inches from the navel), the lateral thigh, and the upper outer arm. Rotate injection sites to avoid lipohypertrophy, a firm accumulation of fat that can alter absorption rates.
- Wash hands thoroughly. Use a new, sterile insulin syringe for each injection. Common gauge is 27 to 31 gauge, 6 mm to 8 mm length.
- Clean the skin with an alcohol swab and allow it to fully dry. Wet skin increases sting and contamination risk.
- Pinch a fold of skin lightly with your non-dominant hand. Insert the needle at a 45 to 90-degree angle depending on skin and fat thickness. Thin individuals use 45 degrees; those with more subcutaneous fat can use 90 degrees.
- Inject slowly and steadily. Remove the needle, apply light pressure with gauze for a few seconds. Do not rub, as rubbing can accelerate local absorption unevenly.
- Dispose of the needle immediately in a sharps container. Never recap.
What Dose Should You Use?
Dose ranges in the published literature varied by indication. The Corpas et al. 1992 study in healthy older men used approximately 0.5 mcg per kg twice daily; the Vittone et al. 1997 trial used a single nightly dose in a comparable range. The original Geref prescribing information for pediatric GH deficiency used weight-based dosing (0.03 mg per kg per day).
For adults, compounding prescriptions in clinical practice commonly fall between 100 and 300 mcg per night, calibrated by the prescribing physician to IGF-1 levels and symptom response. There is no FDA-approved adult dosing standard because the branded product was discontinued. All current adult use is off-label or compounded. This page does not recommend a specific dose. Work with a licensed prescriber who can order baseline and follow-up IGF-1 testing.
| Context | Dose Range Seen in Literature or Practice | Evidence Source |
|---|---|---|
| Healthy older adults (research) | Roughly 0.5 mcg/kg BID or single nightly dose | Corpas et al. 1992; Vittone et al. 1997 |
| Pediatric GHD (original approval) | 0.03 mg/kg/day SC at bedtime | Geref prescribing information (FDA) |
| Adult compounding practice | 100 to 300 mcg nightly | Prescribing convention; not RCT-derived |
When Is the Best Time to Take Sermorelin?
Nighttime injection, 30 to 60 minutes before sleep, is the standard clinical recommendation. The justification is mechanistic and grounded in established circadian GH physiology. The dominant GH pulse in healthy adults occurs during the first episode of slow-wave (stage 3) sleep, typically 60 to 90 minutes after sleep onset, and is driven by a surge of hypothalamic GHRH release. Injecting sermorelin just before sleep delivers exogenous GHRH receptor stimulation at the time the pituitary somatotrophs are already primed to respond. This amplifies rather than replaces the natural pulse.
Two additional timing considerations reinforce this recommendation. First, insulin suppresses GH secretion at the pituitary. A meal within 2 to 3 hours of injection raises insulin and blunts the GH pulse amplitude. Second, somatostatin (the endogenous GH inhibitor) is at its nadir during early sleep, reducing inhibitory competition. Taken together, fasted nighttime injection aligns with a window of maximum GHRHR responsiveness. This is mechanism-level reasoning with supportive observational data, not a controlled crossover trial comparing timing windows in adults using sermorelin specifically.
What Do Most Guides Get Wrong About Sermorelin?
This section covers what commodity pages omit or misstate.
Bioavailability of non-injectable forms. Sublingual drops and oral capsules marketed as sermorelin have no published bioavailability data in humans. Sermorelin is a 29-amino-acid peptide with a molecular weight of roughly 3,357 Da. Gastric pepsin and intestinal proteases cleave peptide bonds efficiently. Even if a small fraction survived gastric transit, first-pass hepatic extraction would further reduce systemic exposure. No published human pharmacokinetic data for oral sermorelin exists. Products sold this way may not be inactive, but the burden of proof for efficacy is entirely absent.
The Geref discontinuation matters for sourcing. The FDA-approved branded product was withdrawn from the U.S. market. Sermorelin is now produced exclusively by compounding pharmacies. Compounded peptides are not held to the same lot-to-lot consistency requirements as approved drugs. Potency can vary. This is not a reason to avoid compounded sermorelin, but it is a reason to demand a certificate of analysis from an independent third-party laboratory for every vial lot.
Desensitization with long-term use is real but often understated. Chronic continuous GHRHR stimulation can downregulate receptor expression and reduce GH pulse amplitude over time. This is the mechanistic basis for cycling protocols (common patterns include 5 days on, 2 days off, or 3 months on, 1 month off). However, the optimal cycle length is not established by controlled human trials. Cycling is a reasonable precaution, not an evidence-based rule.
IGF-1 monitoring is not optional. Elevated IGF-1 above the age-adjusted normal range is associated with increased cancer risk in observational data. Starting sermorelin without a baseline IGF-1 test and periodic follow-up testing is a substantive clinical risk, not a formality.
How Long Does Reconstituted Sermorelin Stay Potent?
Lyophilized sermorelin is stable at room temperature for months when stored away from heat and light. The critical vulnerability begins at reconstitution. Once in solution, peptide bonds are exposed to hydrolysis, oxidation, and aggregation.
Using bacteriostatic water (which contains 0.9% benzyl alcohol as a preservative) rather than plain sterile water meaningfully extends usable shelf life by suppressing microbial growth. Refrigeration at 2 to 8 degrees Celsius further slows degradation by reducing reaction kinetics. Based on general peptide stability principles and compounding pharmacy guidance, reconstituted sermorelin stored at 2 to 8 degrees Celsius is typically considered usable for up to 14 to 30 days. Beyond that window, potency loss is plausible even without visible changes.
Visual signs that a vial should be discarded regardless of age: cloudiness, visible particulates, color change from clear to yellowish, or a visible film on the glass. Freezing the reconstituted solution is generally not recommended because freeze-thaw cycles can cause peptide aggregation and loss of potency, unlike lyophilized powder which tolerates freezing well.
How Does Sermorelin Compare to Alternatives?
| Factor | Sermorelin | CJC-1295 with DAC | Ipamorelin | Exogenous rGH (e.g., Norditropin) |
|---|---|---|---|---|
| Mechanism | GHRH receptor agonist | GHRH receptor agonist (albumin-bound) | Ghrelin receptor (GHS-R1a) agonist | Direct GH replacement |
| Half-life | Roughly 10 to 20 min | Several days (albumin binding) | Roughly 2 hours | Roughly 2 to 4 hours (SC) |
| Pulsatility preserved | Yes | Partially (blunts pulsatility) | Yes | No |
| Feedback loop intact | Yes | Partially | Yes | No (suppresses endogenous GH) |
| Human RCT data | Yes (limited, older trials) | Very limited | Very limited | Extensive (FDA approved) |
| Regulatory status (US) | Compounded Rx only | Compounded Rx only | Compounded Rx only | FDA-approved for GHD |
| Where sermorelin loses | Less potent GH elevation than exogenous GH; shorter track record than rGH in adults | Fewer injections needed with CJC-DAC | Ipamorelin has more specific GH release with less cortisol/prolactin stimulation in some studies | rGH has definitive FDA approval and extensive long-term safety data for GHD |
How Do You Read a Sermorelin Label and COA?
A compounded sermorelin vial label should state: the peptide name (sermorelin acetate), total mass in the vial (e.g., 6 mg or 9 mg), concentration after reconstitution if pre-mixed, the lot number, expiration date, and prescribing pharmacy name and license number. If any of these are missing, contact the pharmacy before using the product.
A certificate of analysis (COA) from an independent third-party laboratory should include all of the following:
- HPLC purity: Should be 98% or higher. Lower purity means peptide-related impurities are present. The HPLC trace itself, not just the summary number, should be available on request.
- Mass spectrometry (MS) confirmation: Should confirm a molecular weight consistent with sermorelin acetate, approximately 3,357 Da. This confirms correct sequence, not just correct mass.
- Endotoxin (LAL test): Should be below 1 EU per mg. Endotoxin contamination causes inflammatory reactions and is the most common quality-control failure in peptide products.
- Sterility testing: For injectable compounds, USP sterility tests should be performed. Ask for this documentation specifically.
- Water content: Lyophilized peptides retain variable water. High water content by Karl Fischer titration means actual peptide mass per vial is lower than labeled. A reputable supplier accounts for this.
Red flags: a COA that lists only HPLC purity without mass spec confirmation, a COA issued by the vendor's in-house lab rather than an independent party, or any refusal to share the COA on request.
FAQ
How do you take sermorelin peptide?
Sermorelin is administered as a subcutaneous injection, most commonly into abdominal fat. The lyophilized powder is reconstituted with bacteriostatic water, drawn into an insulin syringe, and injected at night before sleep. Oral and transdermal forms have not demonstrated meaningful bioavailability in published research.
What dose of sermorelin should I use?
Clinical trials used doses roughly in the 0.2 to 0.3 mg per day range for adults. Compounding prescriptions commonly range from 100 to 300 mcg per injection nightly. Exact dosing should be set by a licensed prescriber based on IGF-1 levels and clinical response.
When is the best time to take sermorelin?
Nighttime injection 30 to 60 minutes before sleep is standard. This aligns with the largest natural GH pulse that occurs during early slow-wave sleep. Injecting at this time may amplify rather than override physiologic GH release.
How do you reconstitute sermorelin?
Add bacteriostatic water (typically 1 to 2 mL per vial depending on vial concentration) slowly along the vial wall. Do not shake. Gently swirl until powder fully dissolves. The solution should be clear and colorless. Calculate concentration in mcg per mL before drawing your dose.
How long does reconstituted sermorelin stay stable?
Reconstituted sermorelin stored at 2 to 8 degrees Celsius retains acceptable potency for roughly 14 to 30 days with bacteriostatic water, based on general peptide stability principles and manufacturer guidance. Discard if the solution becomes cloudy or develops visible particles.
Can you take sermorelin orally?
No published human data supports meaningful oral bioavailability for sermorelin. As a 29-amino-acid peptide, it is rapidly degraded by gastric proteases before systemic absorption. Subcutaneous injection remains the only administration route with demonstrated pharmacodynamic effect in humans.
What should you avoid eating before a sermorelin injection?
Avoid high-carbohydrate or high-fat meals for 2 to 3 hours before injection. Elevated insulin and free fatty acids blunt GHRH-stimulated GH release at the pituitary and hypothalamic level. A fasted or low-carb state maximizes the GH pulse amplitude.
How is sermorelin different from ipamorelin or CJC-1295?
Sermorelin is a truncated GHRH analogue with a plasma half-life of roughly 10 to 20 minutes. CJC-1295 with DAC has a much longer half-life of several days due to albumin binding. Ipamorelin is a ghrelin mimetic acting at the GHS-R1a receptor. They differ in pulse physiology, receptor specificity, and the evidence base supporting them.
What are the most common side effects of sermorelin injections?
The most commonly reported side effects in clinical trials include injection-site redness or pain, flushing, headache, and transient drowsiness. These were generally mild and self-limiting. Elevated IGF-1 beyond the normal range is a risk with prolonged or high-dose use.
Does sermorelin require a prescription?
Yes. In the United States, sermorelin acetate is a prescription compound. The branded product Geref was discontinued, and sermorelin is now available primarily through compounding pharmacies under a valid prescription. It is not legally available as an over-the-counter supplement.
How do you read a sermorelin COA to verify purity?
A credible COA should show HPLC purity of 98% or greater, mass spectrometry confirmation of the correct molecular weight (approximately 3,357 Da for sermorelin acetate), and endotoxin levels below 1 EU per mg. Reject any product without an independent third-party assay or with missing mass spec data.
Sources
- Corpas E, Harman SM, Pineyro MA, Roberson R, Blackman MR. "Growth hormone (GH)-releasing hormone-(1-29) twice daily reverses the decreased GH and insulin-like growth factor-I levels in old men." Journal of Clinical Endocrinology and Metabolism. 1992; 75(2): 530-535.
- Vittone J, Blackman MR, Busby-Whitehead J, et al. "Effects of single nightly injections of growth hormone-releasing hormone (GHRH 1-29) in healthy elderly men." Metabolism. 1997; 46(1): 89-96.
- Geref (sermorelin acetate for injection) Prescribing Information. Serono Laboratories. Archived FDA label data.
- Frohman LA, Jansson JO. "Growth hormone-releasing hormone." Endocrine Reviews. 1986; 7(3): 223-253. (foundational review of GHRH receptor physiology)
- Van Cauter E, Plat L, Copinschi G. "Interrelations between sleep and the somatotropic axis." Sleep. 1998; 21(6): 553-566.
- Alba M, Fintini D, Sagazio A, et al. "Once-daily administration of CJC-1295, a long-acting growth hormone-releasing hormone analog, normalizes growth in the GHRH knockout mouse." American Journal of Physiology Endocrinology and Metabolism. 2006; 291(6): E1290-E1294.
- U.S. Pharmacopeial Convention. USP General Chapter 1 (Injections and Implanted Drug Products); and USP 71 (Sterility Tests). USP-NF online. Accessed 2026.
- Ho KKY; GH Research Society. "Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: a statement of the GH Research Society." European Journal of Endocrinology. 2007; 157(6): 695-700.
Footer Disclaimers
Platform: This page is published by FormBlends for educational and informational purposes only. It does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any peptide or hormone-related protocol.
Research Compound or Compounded Medication: Sermorelin acetate is not currently available as an FDA-approved drug product for adults in the United States. It is available through licensed compounding pharmacies under a valid prescription. Compounded drugs are not FDA-approved and may differ in potency and purity from approved products.
Results: Individual outcomes vary. Information presented here reflects population-level research findings and does not guarantee any specific result for any individual.
Trademark: Geref is a trademark of its respective owner. FormBlends is not affiliated with any pharmaceutical manufacturer referenced on this page. All product and company names are used for identification and informational purposes only.